Anti-LXRA/B

Anti-LXRA/B
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-R33324-100UG 100 µg - -

3 - 10 Werktage*

755,00 €
 
0.5 mg/ml in 1X TBS, pH7.3, with 0.5% BSA (US sourced) and 0.02% sodium azide. Additional name(s)... mehr
Produktinformationen "Anti-LXRA/B"
0.5 mg/ml in 1X TBS, pH7.3, with 0.5% BSA (US sourced) and 0.02% sodium azide. Additional name(s) for this target protein: Liver X receptor, alpha/beta, NR1H3, NR1H2 Protein function: Nuclear receptor. Interaction with RXR shifts RXR from its role as a silent DNA-binding partner to an active ligand- binding subunit in mediating retinoid responses through target genes defined by LXRES. LXRES are DR4-type response elements characterized by direct repeats of two similar hexanuclotide half- sites spaced by four nucleotides. Plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism. Exhibits a ligand-dependent transcriptional activation activity (PubMed:25661920). [The UniProt Consortium]
Schlagworte: Anti-LXRA, Anti-NR1H3, Anti-Liver X receptor alpha, Anti-Oxysterols receptor LXR-alpha, Anti-Nuclear receptor subfamily 1 group H member 3, LXRA/B Antibody
Hersteller: NSJ Bioreagents
Hersteller-Nr: R33324

Eigenschaften

Anwendung: WB, ELISA (peptide)
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Goat
Spezies-Reaktivität: human, mouse, rat
Immunogen: Amino acids CRLQDKKLPPLLSEI were used as the immunogen for this LXRA/B antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-LXRA/B"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen